Mirati Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, Oct. 26, 2020 /PRNewswire/ — Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell in an underwritten public offering $700.0 million of shares of its common stock and a selling stockholder intends to offer 375,000 shares in the offering. In…


Continue Reading

HEDGE accordingly